Patent details

EP2152195 Title: PEPTIDE PHARMACEUTICAL FOR ORAL DELIVERY

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2152195
WO Application Number:
US2008006804
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP08767936.1
WO Publication Number:
WO2008150426
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
29/05/2008
Grant date:
11/11/2015
EP Publication Date:
17/02/2010
WO Publication Date:
11/12/2008
Claims Translations Received Date:
Claims Translation B1 Received Date:
08/01/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/11/2015
EP B1 Publication Date:
11/11/2015
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
28/05/2028
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
11/11/2015
 
 

 

Name:
Enteris BioPharma, Inc.
Address:
83 Fulton Street, BOONTON, NJ 07005, United States of America (US)

Domicile Holder

Name:
ir. H.J.G. Lips c.s.
From:
01/03/2016
Address:
Haagsch Octrooibureau Breitnerlaan 146, 2596 HG, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
STERN, William
Address:
Tenafly, New Jersey 07670, United States of America (US)

2

Name:
CONSALVO, Angelo, P.
Address:
Monroe, New York 10950, United States of America (US)

Priority

1

Priority Patent Number:
128210
Priority Date:
28/05/2008
Priority Country:
United States of America (US)

2

Priority Patent Number:
940598 P
Priority Date:
29/05/2007
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 9/16; A61K 9/20; A61K 9/28; A61K 9/50; A61K 38/23; A61K 38/29;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
09/16
Publication date:
02/03/2016
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
47/15
Publication date:
19/11/2015
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201551
Publication date:
16/12/2015
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
201546
Publication date:
11/11/2015
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/05/2025
Annual Fee Number:
18
Annual Fee Amount:
1200 Euro
Last Annual Payment Date:
15/04/2024
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
1100 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
01/03/2016 Outgoing Correspondence Outgoing Letter 1 PDF /4/1/2/4/1/0800014214/docs/ep08767936.1_2_39222l271.pdf
08/01/2016 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /4/1/2/4/1/0800014214/docs/ep08767936.1_1_incomingcorrespondencepaper20160113094404746.pdf
08/01/2016 Claims First filed claims 9 PDF /4/1/2/4/1/0800014214/docs/ep08767936.1_3_claims20160113094404799.pdf
04/01/2016 Incoming Correspondence Paper Response applicant or agent 1 PDF /4/1/2/4/1/0800014214/docs/ep08767936.1_0_incomingcorrespondencepaper20160107075617785.pdf